BIO 2025 | Cellistic

🧬 iPSCs are reshaping the future of allogeneic cell therapy—and Cellistic is leading the charge. I had the chance to connect with Tarran Pierfelice, PhD, Chief Commercial Officer, and Stefan Braam, PhD, Chief Technology Officer and one of the founders of Cellistic, during our insights series at BIO 2025.

We talked about the promise and power of induced pluripotent stem cells (iPSCs), what makes Cellistic’s platform unique, and the mindset it takes to drive innovation from the lab to the clinic. They are on a mission to drive the next wave of cell therapy manufacturing!

I would like to thank both Tarran and Stefan for taking the time to meet with me. It was great seeing you!